Literature DB >> 26314301

Epidemiology of Malignant and Non-Malignant Primary Brain Tumors in Jordan.

Ahmad F Tamimi1, Iskandar Tamimi, Mohamad Abdelaziz, Qusai Saleh, Fatimah Obeidat, Maisa Al-Husseini, William Haddadin, Faleh Tamimi.   

Abstract

BACKGROUND: There is lack of knowledge on the epidemiological characteristics of brain tumors in Middle Eastern countries. The objective of this study was to study the epidemiological features of primary brain tumors in Jordan.
METHODS: We conducted a prospective cohort study incorporating data from 16 hospitals in Jordan during a 1 year period (May 1, 2011-April 30, 2012). All primary brain tumors diagnosed in Jordan during the study period were identified. The following parameters were retrieved from patients' files: age, gender, histological type, and location. The demographic data of the country was obtained from the National Department of Statistics.
RESULTS: A total of 313 primary brain tumors were identified during the study period. The incidence of primary brain tumors in Jordan among the general population was 5.01 per 100,000 person-years (5.38 in females and 4.65 in males). The incidence in pediatric, adult, and elderly patients was 2.09, 7.29, and 14.38 per 100,000 person-years, respectively. The most common histological types were meningioma (26.2%), glioblastoma (18.9%), astrocytoma (14.1%), and pituitary adenoma (9.3%).
CONCLUSIONS: The incidence of primary brain tumors in the Jordanian population is relatively low, in part due to the young age of the general population.

Entities:  

Mesh:

Year:  2015        PMID: 26314301     DOI: 10.1159/000438926

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Descriptive Epidemiology of Brain and Central Nervous System Tumours: Results from Iran National Cancer Registry, 2010-2014.

Authors:  Amir Salimi; Alireza Zali; Amir Saeid Seddighi; Afsoun Seddighi; Shakila Meshkat; Morteza Hosseini; Amir Nikouei; Mohammad Esmaeil Akbari
Journal:  J Cancer Epidemiol       Date:  2020-09-18

2.  The Epidemiology of Primary Central Nervous System Tumors at the National Neurologic Institute in Saudi Arabia: A Ten-Year Single-Institution Study.

Authors:  Amna Almutrafi; Yara Bashawry; Wafaa AlShakweer; Musa Al-Harbi; Abdullah Altwairgi; Sadeq Al-Dandan
Journal:  J Cancer Epidemiol       Date:  2020-02-15

3.  AB Blood Group Confers Higher Risk for Primary Brain Tumors in Pediatrics.

Authors:  Abdulrahman Al Shudifat; Hala Al Suqi; Kutada Soub; Leen Al Nemrawi; Moa'tasem Abu Jaber; Mohammad Al Barbarawi; Nour Shewaikani; Yazan El Adwan; Assem Al Refaei
Journal:  Risk Manag Healthc Policy       Date:  2021-09-27

4.  Prevalence, Distribution, and Histopathological Features of Malignant Tumors Reported at Tertiary Level in Afghanistan: A 3-Year Study.

Authors:  Haider Ali Malakzai; Ahmed Maseh Haidary; Saleema Gulzar; Mujtaba Haidari; Abdul Sami Ibrahimkhil; Ramin Saadaat; Ahmadullah Hakimi; Sayed Murtaza Sadat Hofiani; Soma Rahmani; Jamshid Abdul-Ghafar
Journal:  Cancer Manag Res       Date:  2022-08-30       Impact factor: 3.602

5.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017.

Authors:  Esmaeil Mohammadi; Erfan Ghasemi; Sina Azadnajafabad; Negar Rezaei; Sahar Saeedi Moghaddam; Sepideh Ebrahimi Meimand; Nima Fattahi; Zohreh Habibi; Kourosh Karimi Yarandi; Abbas Amirjamshidi; Farideh Nejat; Farzad Kompani; Ali H Mokdad; Bagher Larijani; Farshad Farzadfar
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.